(2 years, 4 months ago)
Commons Chamber(2 years, 11 months ago)
Commons ChamberWe absolutely will, and our plan contains an ambition to significantly increase the denial of assets to the criminal fraternity. We know that this business, if it is a business—a horrible business—is prosecuted for profit. It is all about the money, so if we can make it a low-return, high-risk business, we will deter a lot of people from getting involved.
I welcome the focus in the strategy on treatment and recovery; £780 million is a significant investment, and I commend the Government for that. On supply and demand, I fear we are being offered an enhanced version of the same general approach that has failed for the last 50 years, and I am sad to say that it will fail for the next 10 years. On drug consumption rooms, the Minister said that the evidence is “patchy”. Surely, then, this is the time for some proper trials and pilots so that we can get the evidence. There is a lot of talk in the strategy about evidence; surely the Government have a duty now to allow some of those trials to get the evidence that these drug consumption rooms—I prefer to call them overdose prevention centres—can save lives.
As I say, I think there is a big difference with this plan, which is that on the supply side we are very much coming at this from an economic point of view. We have done an enormous amount of work to examine the nature of the business. We are not necessarily looking at the individuals involved, who very often are replaced if they are arrested—sometimes within hours—but fundamentally at the structure of the business, and interfering with it in a way that means it does not reoccur, using the method of distribution and communication against the business to make sure that we stamp it out. We are showing success across the country, particularly on county lines.
On drug consumption rooms, as I say, we remain open to evidence. We are looking at the evidence that has been presented by the Scottish Government, and we will respond to the Minister there shortly. However, as I say, even if that evidence was compelling—I am not convinced that it is at the moment—there are legislative obstacles that mean that we have no option for the moment but to focus on health investment and making sure that we ramp up treatment and rehabilitation, which we have seen have effect across the world.